<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">JAMA Pediatr</journal-id><journal-id journal-id-type="iso-abbrev">JAMA Pediatr</journal-id><journal-id journal-id-type="pmc-domain-id">3211</journal-id><journal-id journal-id-type="pmc-domain">jamasd</journal-id><journal-title-group><journal-title>JAMA Pediatrics</journal-title></journal-title-group><issn pub-type="ppub">2168-6203</issn><issn pub-type="epub">2168-6211</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>JAMA Network</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10167598</article-id><article-id pub-id-type="pmcid-ver">PMC10167598.1</article-id><article-id pub-id-type="pmcaid">10167598</article-id><article-id pub-id-type="pmcaiid">10167598</article-id><article-id pub-id-type="pmid">37155175</article-id><article-id pub-id-type="doi">10.1001/jamapediatrics.2023.1047</article-id><article-id pub-id-type="publisher-id">poi230016</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="category" specific-use="electronic"><subject>Research</subject></subj-group><subj-group subj-group-type="domain" specific-use="print"><subject>Research</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Investigation</subject></subj-group><subj-group subj-group-type="online-first"><subject>Online First</subject></subj-group><subj-group subj-group-type="allowCommenting"><subject>Comments</subject></subj-group></article-categories><title-group><article-title>Maternal Opioid Use Disorder and the Risk of Postneonatal Infant Mortality</article-title><alt-title alt-title-type="headline">Maternal Opioid Use Disorder and the Risk of Postneonatal Infant Mortality</alt-title><alt-title alt-title-type="running-head">Maternal Opioid Use Disorder and the Risk of Postneonatal Infant Mortality</alt-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Grossarth</surname><given-names initials="S">Sarah</given-names></name><degrees>MPH</degrees><xref rid="poi230016aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Osmundson</surname><given-names initials="SS">Sarah S.</given-names></name><degrees>MD</degrees><degrees>MS</degrees><xref rid="poi230016aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wiese</surname><given-names initials="AD">Andrew D.</given-names></name><degrees>PhD</degrees><degrees>MPH</degrees><xref rid="poi230016aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="poi230016aff3" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Phillips</surname><given-names initials="SE">Sharon E.</given-names></name><degrees>MSPH</degrees><xref rid="poi230016aff4" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Pham</surname><given-names initials="A">Amelie</given-names></name><degrees>MD</degrees><xref rid="poi230016aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Leech</surname><given-names initials="AA">Ashley A.</given-names></name><degrees>PhD</degrees><degrees>MS</degrees><xref rid="poi230016aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="poi230016aff3" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Patrick</surname><given-names initials="SW">Stephen W.</given-names></name><degrees>MD</degrees><degrees>MPH</degrees><degrees>MS</degrees><xref rid="poi230016aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="poi230016aff3" ref-type="aff">
<sup>3</sup>
</xref><xref rid="poi230016aff5" ref-type="aff">
<sup>5</sup>
</xref><xref rid="poi230016aff6" ref-type="aff">
<sup>6</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Spieker</surname><given-names initials="AJ">Andrew J.</given-names></name><degrees>PhD</degrees><xref rid="poi230016aff4" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Grijalva</surname><given-names initials="CG">Carlos G.</given-names></name><degrees>MD</degrees><degrees>MPH</degrees><xref rid="poi230016aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="poi230016aff7" ref-type="aff">
<sup>7</sup>
</xref><xref rid="poi230016aff8" ref-type="aff">
<sup>8</sup>
</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Adgent</surname><given-names initials="MA">Margaret A.</given-names></name><degrees>PhD</degrees><degrees>MSPH</degrees><xref rid="poi230016aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="poi230016aff1"><label>1</label>Department of Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee</aff><aff id="poi230016aff2"><label>2</label>Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Vanderbilt University Medical Center, Nashville, Tennessee</aff><aff id="poi230016aff3"><label>3</label>Vanderbilt Center for Child Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee</aff><aff id="poi230016aff4"><label>4</label>Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee</aff><aff id="poi230016aff5"><label>5</label>Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee</aff><aff id="poi230016aff6"><label>6</label>Mildred Stahlman Division of Neonatology, Vanderbilt University Medical Center, Nashville, Tennessee</aff><aff id="poi230016aff7"><label>7</label>Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee</aff><aff id="poi230016aff8"><label>8</label>Veterans&#8217; Health Administration Tennessee Valley Healthcare System, Geriatric Research Education and Clinical Center (GRECC), Nashville</aff><author-notes><title>Article Information</title><p><bold>Accepted for Publication:</bold> March 17, 2023.</p><p content-type="published-online"><bold>Published Online:</bold> May 8, 2023. doi:<uri content-type="doi">10.1001/jamapediatrics.2023.1047</uri></p><corresp id="poi230016cor1"><bold>Corresponding Author:</bold> Margaret A. Adgent, PhD, MSPH, Department of Health Policy, Vanderbilt University Medical Center, 2525 West End Ave, 7th Floor, Nashville, TN 37203 (<email xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="margaret.a.adgent@vumc.org">margaret.a.adgent@vumc.org</email>).</corresp><p content-type="author-contributions"><bold>Author Contributions:</bold> Dr Adgent had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.</p><p><italic toggle="yes">Concept and design:</italic> Grossarth, Osmundson, Wiese, Pham, Leech, Grijalva, Adgent.</p><p><italic toggle="yes">Acquisition, analysis, or interpretation of data:</italic> All authors.</p><p><italic toggle="yes">Drafting of the manuscript:</italic> Grossarth, Leech.</p><p><italic toggle="yes">Critical revision of the manuscript for important intellectual content:</italic> All authors.</p><p><italic toggle="yes">Statistical analysis:</italic> Grossarth, Wiese, Phillips, Leech, Spieker, Adgent.</p><p><italic toggle="yes">Administrative, technical, or material support:</italic> Osmundson, Wiese, Patrick, Spieker, Grijalva.</p><p><italic toggle="yes">Supervision:</italic> Osmundson, Pham, Spieker, Grijalva, Adgent.</p><p content-type="COI-statement"><bold>Conflict of Interest Disclosures:</bold> Dr Osmundson reported grants from the National Institutes of Health during the conduct of the study. Dr Wiese reported grants from the National Institute on Drug Abuse (K01DA051683) during the conduct of the study and personal fees from the Tennessee Department of Health outside the submitted work. Dr Patrick reported grants from the National Institute of Child Health and Human Development (P50DA046351) during the conduct of the study and grants from the National Institute on Drug Abuse, the Center for Medicare and Medicaid Innovation, the Robert Wood Johnson Foundation, the National Institute of Child Health and Human Development, the Boedecker Foundation, the Agency for Healthcare Research and Quality, and the National Institute of Mental Health outside the submitted work. Dr Spieker reported grants from the National Institutes of Health during the conduct of the study. Dr Grijalva reported grants from the National Institutes of Health during the conduct of the study, consultant fees from Merck, and grants from the National Institutes of Health, the US Centers for Disease Control and Prevention, the Agency for Healthcare Research and Quality, the US Food and Drug Administration, Syneos Health, and Sanofi outside the submitted work. Dr Adgent reported grants from the National Institutes of Health and the US Food and Drug Administration during the conduct of the study. No other disclosures were reported.</p><p content-type="funding-statement"><bold>Funding/Support:</bold> This study was supported in part by the US Department of Health and Human Services, the National Institutes of Health (5K12HD043483, K01DA051683, K23DA047476, K01DA050740, R01 AG043471, P50HD106446-02, R01DA045729, and 5UL1TR002243-03).</p><p><bold>Role of the Funder/Sponsor:</bold> The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.</p><p content-type="data-sharing-statement"><bold>Data Sharing Statement:</bold> See <xref rid="note-POI230016-1-s" ref-type="supplementary-material">Supplement 2</xref>.</p><p><bold>Additional Contributions:</bold> We thank the Tennessee Division of TennCare of the Department of Finance and Administration, which provided data for the study. We thank the Tennessee Department of Health for providing data for the study.</p></author-notes><pub-date pub-type="epub" iso-8601-date="2023-05-08T10:00"><day>8</day><month>5</month><year>2023</year></pub-date><pub-date pub-type="ppub"><month>7</month><year>2023</year></pub-date><volume>177</volume><issue>7</issue><issue-id pub-id-type="pmc-issue-id">435333</issue-id><fpage>675</fpage><lpage>683</lpage><history><date date-type="received"><day>19</day><month>1</month><year>2023</year></date><date date-type="accepted"><day>17</day><month>3</month><year>2023</year></date></history><pub-history><event event-type="pmc-release"><date><day>08</day><month>05</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>08</day><month>05</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-05-08 00:25:13.387"><day>08</day><month>05</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>Copyright 2023 American Medical Association. All Rights Reserved.</copyright-statement></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="jamapediatr-e231047.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf-version" xlink:href="jamapediatr-e231047.pdf">jamapediatr-e231047.pdf</self-uri><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="silverchair" xlink:href="https://jamanetwork.com/journals/archpedi/fullarticle/10.1001/jamapediatrics.2023.1047"/><abstract abstract-type="teaser" specific-use="electronic"><p>This study characterizes the risk of postneonatal infant mortality among infants with a neonatal opioid withdrawal syndrome diagnosis or born to individuals with opioid use disorder.</p></abstract><abstract abstract-type="key-points"><title>Key Points</title><sec id="ab-poi230016-1"><title>Question</title><p>What is the risk of postneonatal infant mortality among infants with neonatal opioid withdrawal syndrome (NOWS) diagnosis or born to individuals with opioid use disorder (OUD)?</p></sec><sec id="ab-poi230016-2"><title>Findings</title><p>In this cohort study of 390&#8201;075 infants, after adjusting for maternal and infant characteristics, the risk of postneonatal infant mortality was significantly higher for those born to individuals with OUD or diagnosed with NOWS as compared with unexposed infants.</p></sec><sec id="ab-poi230016-3"><title>Meaning</title><p>In this study, maternal OUD and NOWS diagnosis were associated with an increased risk of postneonatal infant mortality.</p></sec></abstract><abstract><sec id="ab-poi230016-4"><title>Importance</title><p>The risk of serious long-term outcomes for infants born to individuals with opioid use disorder (OUD) is not fully characterized, nor is it well understood whether risks are modified by infant diagnosis of neonatal opioid withdrawal syndrome (NOWS).</p></sec><sec id="ab-poi230016-5"><title>Objective</title><p>To characterize the risk of postneonatal infant mortality among infants with a NOWS diagnosis or born to individuals with OUD.</p></sec><sec id="ab-poi230016-6"><title>Design, Setting, and Participants</title><p>The study team conducted a retrospective cohort study of 390&#8201;075 infants born from 2007 through 2018 to mothers who were enrolled in Tennessee Medicaid from 183 days prior to delivery through 28 days post partum (baseline). Maternal and infant baseline characteristics were measured using administrative claims and birth certificates, and infants were followed up from day 29 post partum through day 365 or death. Deaths were identified using linked death certificates through 2019. These data were analyzed from February 10, 2022, through March 3, 2023.</p></sec><sec id="ab-poi230016-7"><title>Exposure</title><p>Infant exposures included birth to an individual with OUD or postnatal diagnosis of NOWS. The study team defined a pregnant individual&#8217;s OUD status (maternal OUD) as having OUD diagnosis or a maintenance medication prescription fill during baseline; this study defined NOWS as having NOWS diagnosis up to day 28. Groups were categorized by exposures as maternal OUD with NOWS (OUD positive/NOWS positive), maternal OUD without NOWS (OUD positive/NOWS negative), no documented maternal OUD with NOWS (OUD negative/NOWS positive), and no documented maternal OUD or NOWS (OUD negative/NOWS negative, unexposed).</p></sec><sec id="ab-poi230016-8"><title>Main Outcome and Measures</title><p>The outcome was postneonatal infant death, confirmed by death certificates. Cox proportional hazards models were used, adjusting for baseline maternal and infant characteristics, to estimate adjusted hazard ratios (aHRs) and 95% CIs for the association between maternal OUD or NOWS diagnosis with postneonatal death.</p></sec><sec id="ab-poi230016-9"><title>Results</title><p>Pregnant individuals in the cohort had a mean (SD) age of 24.5 (5.2) years; 51% of infants were male. The study team observed 1317 postneonatal infant deaths and incidence rates of 3.47 (OUD negative/NOWS negative, 375&#8201;718), 8.41 (OUD positive/NOWS positive, 4922); 8.95 (OUD positive/NOWS negative, 7196), and 9.25 (OUD negative/NOWS positive, 2239) per 1000 person-years. After adjustment, the risk of postneonatal death was elevated for all groups, relative to the unexposed: OUD positive/NOWS positive (aHR, 1.54; 95% CI, 1.07-2.21), OUD positive/NOWS negative (aHR, 1.62; 95% CI, 1.21-2.17), and OUD negative/NOWS positive (aHR, 1.64; 95% CI, 1.02-2.65).</p></sec><sec id="ab-poi230016-10"><title>Conclusions and Relevance</title><p>Infants born to individuals with OUD or with a NOWS diagnosis had an increased risk of postneonatal infant mortality. Future work is necessary to create and evaluate supportive interventions for individuals with OUD during and after pregnancy to reduce adverse outcomes.</p></sec></abstract><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>